Theriva Biologics, Inc. (TOVX)
NYSE · Healthcare
Theriva Biologics, Inc. Shareholder Equity 2010–2011
Theriva Biologics, Inc. annual/quarterly shareholder equity history from 2010 to 2011. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Theriva Biologics, Inc. shareholder equity for the quarter ending December 31, 2011 were 7.1M, a 97.23% increase year-over-year.
- Theriva Biologics, Inc. shareholder equity for 2011 were 7.1M, a 97.23% increase from 2010.
- Theriva Biologics, Inc. shareholder equity for 2010 were 3.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Theriva Biologics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2011 | $7 |
| 2010 | $4 |
| Theriva Biologics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2011-12-31 | $7 |
| 2010-12-31 | $4 |
Theriva Biologics, Inc. Shareholder Equity — FAQ
Theriva Biologics, Inc. (TOVX) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TOVX's shareholder equity history?
The chart and table above show Theriva Biologics, Inc.'s shareholder equity by year and by quarter, including the growth rate.